A remarkable story of science and survival, fueled by a frontier mentality that defines UT Southwestern Medical Center, leads to the development of a new drug that gives fresh hope to patients with low-grade gliomas.
Ovarian cancer may start in the fallopian tubes, not the ovaries. Explore the latest research and prevention strategies with Jayanthi Lea, M.D., Division Chief of Gynecologic Oncology at UT Southwestern.
A UT Southwestern gynecologist answers questions about cervical cancer screenings, HPV-associated risks, and screening recommendations for women of all ages.
When an emergency department visit for a bad cough turned into a cancer diagnosis, a new drug – and a movie-worthy standoff with lymphoma – saved Erik Torres’s life.
Discover how Medical Vision Goggles, developed by Samuel Achilefu, Ph.D., may revolutionize cancer surgery by enabling surgeons to see and remove all tumor cells without need for additional surgery.
Cassie Munoz's genetic lung cancer diagnosis at age 29 prompted screenings for her family and led to her mother's cancer diagnosis at an early stage. It also spurred ground-breaking research on their unique mutation.
New gene therapies give kids with beta thalassemia and other severe genetic disorders a chance at a better life. Discover the latest therapeutic advancements.
Jennifer Lowrey lost her parents to Lynch syndrome cancers. Thanks to the Genetic Cancer Prevention Clinic at Harold C. Simmons Comprehensive Cancer Center at UT Southwestern, she is getting the preventive care she needs.
Three women diagnosed with breast cancer share their stories about treatment at UT Southwestern Harold C. Simmons Comprehensive Cancer Center and life after their diagnosis.
Explore how four new grants are expanding cancer clinical trial access, increasing participant diversity, and reducing patients’ expenses at UT Southwestern Harold C. Simmons Comprehensive Cancer Center.
UT Southwestern discusses a blood test approved in August 2024 by the U.S. Food and Drug Administration (FDA) to screen for colorectal cancer – what it can and cannot do, particularly when it’s compared to screening tools already available.
Two studies underway at UT Southwestern are building upon existing nanoparticle technology to deliver brain cancer medications directly to the brain. UT Southwestern discusses how the ReSPECT clinical trials may give hope to patients living with glioblastoma and leptomeningeal disease.
